SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Emmessar Biotech&Nut - Quaterly Results

09 Dec 2023 Evaluate
The revenue for the September 2023 quarter is pegged at Rs. 0.84 millions, about 23.53% up against Rs. 0.68 millions recorded during the year-ago period.A comparatively good net profit growth of 45.19% to Rs. 1.96 millions was reported for the quarter ended September 2023 compared to Rs. 1.35 millions of previous same quarter.Operating Profit saw a handsome growth to 3.11 millions from 2.28 millions in the quarter ended September 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202309 202209 % Var 202309 202209 % Var 202303 202203 % Var
Sales 0.84 0.68 23.53 1.52 2.76 -44.93 10.19 3.65 179.18
Other Income 5.27 4.32 21.99 9.84 8.73 12.71 17.51 19.19 -8.75
PBIDT 3.11 2.28 36.40 4.95 5.16 -4.07 10.60 10.25 3.41
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBDT 3.11 2.28 36.40 4.95 5.16 -4.07 10.60 10.25 3.41
Depreciation 0.24 0.23 4.35 0.48 0.46 4.35 0.94 0.92 2.17
PBT 2.87 2.05 40.00 4.47 4.70 -4.89 9.66 9.33 3.54
TAX 0.91 0.70 30.00 1.96 1.40 40.00 4.63 4.57 1.31
Deferred Tax 0.10 -0.30 -133.33 0.70 0.40 75.00 2.12 0.22 863.64
PAT 1.96 1.35 45.19 2.51 3.30 -23.94 5.03 4.76 5.67
Equity 49.96 49.96 0.00 49.96 49.96 0.00 49.96 49.96 0.00
PBIDTM(%) 370.24 335.29 10.42 325.66 186.96 74.19 104.02 280.82 -62.96

Emmessar Biotech&Nut Share Price

26.29 -0.70 (-2.59%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×